PAREXEL International Corporation:企業の戦略・SWOT・財務情報

◆英語タイトル:PAREXEL International Corporation - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C8762
◆発行会社(調査会社):MarketLine
◆発行日:2018年10月
◆ページ数:54
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥18,725見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥37,450見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥56,175見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

PAREXEL International Corporation – Strategy, SWOT and Corporate Finance Report
Summary

PAREXEL International Corporation – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

PAREXEL International Corporation (PAREXEL or ‘the company’) is a leading global biopharmaceutical services provider. The company’s product and service offerings include Clinical trials management, Biostatistical analysis, Pharmacovigilance, Clinical pharmacology, Regulatory information management (RIM) solutions, ClinPhone Randomization and trial supply management services (RTSM), Electronic data capture systems (EDC), Clinical trial management systems (CTMS), Regulatory information management (RIM) solutions, ClinPhone Randomization and trial supply management services (RTSM), Electronic data capture systems (EDC) and Clinical trial management systems (CTMS), among others. PAREXEL operates in the Americas, Europe, Asia Pacific, the Middle East and Africa. The company is headquartered in Waltham, Massachusetts, the US.

Scope

- Detailed information on PAREXEL International Corporation required for business and competitor intelligence needs
- A study of the major internal and external factors affecting PAREXEL International Corporation in the form of a SWOT analysis
- An in-depth view of the business model of PAREXEL International Corporation including a breakdown and examination of key business segments
- Intelligence on PAREXEL International Corporation’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about PAREXEL International Corporation, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of PAREXEL International Corporation and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess PAREXEL International Corporation as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on PAREXEL International Corporation’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
PAREXEL International Corporation: Company Overview 9
PAREXEL International Corporation: Overview and Key Facts 9
PAREXEL International Corporation: Overview 9
PAREXEL International Corporation: Key Facts 9
PAREXEL International Corporation: Key Employees 10
PAREXEL International Corporation: Key Employee Biographies 12
PAREXEL International Corporation: Major Products and Services 19
PAREXEL International Corporation: Company History 20
PAREXEL International Corporation: Management Statement 25
PAREXEL International Corporation: Locations and Subsidiaries 29
PAREXEL International Corporation: Key Competitors 30
PAREXEL International Corporation: Company Analysis 31
PAREXEL International Corporation: Business Description 31
PAREXEL International Corporation: SWOT Analysis 32
PAREXEL International Corporation: SWOT Overview 32
PAREXEL International Corporation: Strengths 32
PAREXEL International Corporation: Weaknesses 33
PAREXEL International Corporation: Opportunities 33
PAREXEL International Corporation: Threats 34
PAREXEL International Corporation: Corporate Financial Deals Activity 36
PAREXEL International Corporation: Financial Deals Overview 36
PAREXEL International Corporation: Targets and Partners 37
PAREXEL International Corporation: Top Deals 2014 – 2018YTD* 38
PAREXEL International Corporation: Advisors 39
PAREXEL International Corporation: Top Legal Advisors 39
PAREXEL International Corporation: Top Financial Advisors 39
PAREXEL International Corporation: Mergers and Acquisitions 40
PAREXEL International Corporation: Partnership 41
PAREXEL International Corporation: Private Equity and Ownership 42
PAREXEL International Corporation: Recent Developments 43
PAREXEL International Corporation: News and Events Summary 43
PAREXEL International Corporation: Business Expansion 47
PAREXEL International Corporation: Contracts 48
PAREXEL International Corporation: Corporate Governance 49
PAREXEL International Corporation: Financial Deals 49
PAREXEL International Corporation: Financial Performance 50
PAREXEL International Corporation: Market Developments 50
Appendix 52
Contact Us 52
Methodology 52
About MarketLine 53

List of Tables
Table 1: PAREXEL International Corporation: Key Facts
Table 2: PAREXEL International Corporation: Key Employees
Table 3: PAREXEL International Corporation: Company History
Table 4: PAREXEL International Corporation: Locations and Subsidiaries
Table 5: PAREXEL International Corporation: Key Competitors
Table 6: PAREXEL International Corporation: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 7: PAREXEL International Corporation: Targets and Partners
Table 8: PAREXEL International Corporation: Top Deals 2014 - 2018YTD*
Table 9: PAREXEL International Corporation: Legal Advisor Ranking by Value (US$m)
Table 10: PAREXEL International Corporation: Financial Advisor Ranking by Value (US$m)
Table 11: PAREXEL International Corporation: M&A Volume and Value Trend (2014 - YTD*2018)
Table 12: PAREXEL International Corporation: M&A Activity by Geography (2014 - YTD*2018)
Table 13: PAREXEL International Corporation: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 14: PAREXEL International Corporation: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 15: PAREXEL International Corporation: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Table 16: PAREXEL International Corporation: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)
Table 17: PAREXEL International Corporation: News and Events Summary
Table 18: PAREXEL International Corporation: Business Expansion
Table 19: PAREXEL International Corporation: Contracts
Table 20: PAREXEL International Corporation: Corporate Governance
Table 21: PAREXEL International Corporation: Financial Deals
Table 22: PAREXEL International Corporation: Financial Performance
Table 23: PAREXEL International Corporation: Market Developments

List of Figures
Figure 1: PAREXEL International Corporation: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 2: PAREXEL International Corporation: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 3: PAREXEL International Corporation: M&A Activity by Geography (2014 - YTD*2018)
Figure 4: PAREXEL International Corporation: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 5: PAREXEL International Corporation: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 6: PAREXEL International Corporation: Private Equity and Ownership Volume and Value Trend (2014 - YTD*2018)
Figure 7: PAREXEL International Corporation: Private Equity and Ownership Volume by Deal Type (2014 - YTD*2018)

★海外企業調査レポート[PAREXEL International Corporation:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Tosoh Corporation:企業の戦略・SWOT・財務情報
    Tosoh Corporation - Strategy, SWOT and Corporate Finance Report Summary Tosoh Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Anglo-Canadian Mining Corp. (URA):企業概要、財務及び戦略的SWOT分析
    Summary Anglo-Canadian Mining Corp. (Anglo-Canadian) is a mineral exploration company. The company explores and develops natural resources in the US and Canada. Its projects include Quebec Uranium Projects, Colorado Uranium Projects, Uravan Mineral Belt, Lucky Boy Property, Stirrup Claims, Zeus Clai …
  • Wintac Ltd (524758):企業のM&A・提携動向(医療分野)
    Summary Wintac Ltd (Wintac), formerly Recon Limited is a manufacturer and marketer of pharmaceutical formulations. The company’s products include artificial tear, decongestant, anesthetic, antimalarial, anti-emetic, calcium supplement, and others. It provides artificial tear, anti-cholinergic, anti- …
  • B. Braun Melsungen AG:企業の戦略・SWOT・財務分析
    SummaryB. Braun Melsungen AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company. Key F …
  • Mochida Pharmaceutical Co., Ltd. (4534):企業の財務及び戦略的SWOT分析
    Summary Mochida Pharmaceutical Co., Ltd. (Mochida) is a healthcare company that contributes in the field of medical care through its pharmaceuticals, healthcare products, and medical equipment businesses. The company products include Epadel, Atelec, Atedio, Rocornal, Beselna Cream, Florid, Miraclid, …
  • Daikin Industries, Ltd.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Daikin Industries, Ltd. Mergers …
  • Transportadora de Gas del Sur S.A.:企業の戦略・SWOT・財務情報
    Transportadora de Gas del Sur S.A. - Strategy, SWOT and Corporate Finance Report Summary Transportadora de Gas del Sur S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • Visioneering Technologies Inc:製品パイプライン分析
    Summary Visioneering Technologies Inc (VTI) is a medical device company that develops and commercializes on-eye and in-eye solutions for presbyopia, astigmatism and myopia progression control. The company offers technology consists of myopia correction technology, silicone hydrogel material platform …
  • Lariat Energy Ltd. (LE):企業概要、財務及び戦略的SWOT分析
    Summary Lariat Energy Ltd. (Lariat) is an oil and gas company. The company acquires, explores and develops petroleum and natural gas properties. It holds a 2.5% non-operated working interest in seven sections of the Willesden Green North Property. The company has also identified seven potential offs …
  • Global Payments Inc.:企業の戦略・SWOT・財務情報
    Global Payments Inc. - Strategy, SWOT and Corporate Finance Report Summary Global Payments Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Alfa-Beta Vassilopoulos S.A.:企業M&A・提携・投資動向
    SummaryMarketLine's Company Mergers and Acquisitions (M&A), Partnerships and Alliances and Investments reports offer a comprehensive breakdown of the organic and inorganic growth activity undertaken by an organization to sustain its competitive advantage. MarketLines' Alfa-Beta Vassilopoulos S.A. Me …
  • OriGene Technologies Inc-医療機器分野:企業M&A・提携分析
    Summary OriGene Technologies Inc (OriGene) is a research tool company that develops cDNA. The company creates commercial collection of full-length human cDNAs in expression vector. It develops, manufactures and sells genome research and diagnostic products. OriGene’s products include qPCR reagents, …
  • PJSC Detsky Mir (DSKY):企業の財務・戦略的SWOT分析
    PJSC Detsky Mir (DSKY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Suzuken Co., Ltd.:企業の戦略・SWOT・財務分析
    Suzuken Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Suzuken Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Time Dotcom Berhad (TIMECOM):企業の財務・戦略的SWOT分析
    Time Dotcom Berhad (TIMECOM) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Natcore Technology Inc (NXT):企業の財務・戦略的SWOT分析
    Summary Natcore Technology Inc (Natcore) is a solar research and development company that provides products for semiconductor and fiber optic applications. The company’s products include solar cell structures and black silicon cells. It uses liquid phase deposition technology for controlling deposit …
  • Novartis India Limited (500672):企業概要、財務及び戦略的SWOT分析
    Summary Novartis India Limited (Novartis) is a pharmaceutical company. The company develops and manufactures pharmaceutical, consumer health and animal health products. It operates under six divisions pharmaceuticals, alcon, sandoz, vaccines and diagnostics, OTC and animal health. Novartis’ pharmace …
  • Sam-A Pharm. Co., Ltd. (009300):企業の財務及び戦略的SWOT分析
    Summary Sam-A Pharm. Co., Ltd. (Sama Pharm) is a pharmaceutical company that develops generic products that develops and manufactures various products through its product categories such as ETC, OTC and noma. Its ETC products include respiratory, anti-biotics, anti-virals, anti-fungals, dermatology, …
  • Roxi Petroleum PLC (RXP):企業のM&A・提携動向(石油・ガス分野)
    Summary Roxi Petroleum PLC (Roxi) is an oil and gas company that acquires and develops interests in oil and gas assets. The company has interests in exploration and production contract areas comprise the pre-Caspian basin and the Mangyshlak basin in Western Kazakhstan and the Turgai basin in Central …
  • Sanofi India Ltd (SANOFI):企業の財務・戦略的SWOT分析
    Summary Sanofi India Ltd (Sanofi India), formerly Aventis Pharma Ltd, a subsidiary of Sanofi is a healthcare company that manufactures and markets pharmaceutical and prescription products. The company offers products in the form of capsules, tablets, insulin, injection, creams and gels, and solution …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆